Evidence map›Paper›PMID 28853742›Full record

ArticleEuropean journal of clinical nutrition2018

Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function.

R Sinha, I Sinha, A Calcagnotto, N Trushin, J S Haley, T D Schell, J P Richie

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in European journal of clinical nutrition, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04466657 (A Study to Evaluate Antioxidant Therapy for Moderate to Severe COVID-19 With or Without Comorbidities), which is not on this map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04466657 nawithdrawnnot on this mapstarted 2020, after this paper: background citation

A Study to Evaluate Antioxidant Therapy for Moderate to Severe COVID-19 With or Without Comorbidities

TypeinterventionalSponsorObafemi Awolowo UniversityRan2020 to 2021Enrolled0ConditionsCovid-19ArmsAntioxidation Therapy, Standard of Care
3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 101 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Cutaneous Aging in Skin of Color: A Narrative Review.American journal of clinical dermatology · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

R SinhaDepartment of Biochemistry and Molecular Biology, Penn State University College of Medicine, Hershey, PA, USA.
I SinhaDepartment of Biochemistry and Molecular Biology, Penn State University College of Medicine, Hershey, PA, USA.
A CalcagnottoDepartment of Public Health Sciences, Penn State University College of Medicine, Hershey, PA, USA.
N TrushinDepartment of Public Health Sciences, Penn State University College of Medicine, Hershey, PA, USA.
J S HaleyDepartment of Microbiology and Immunology, Penn State University College of Medicine, Hershey, PA, USA.
T D SchellDepartment of Microbiology and Immunology, Penn State University College of Medicine, Hershey, PA, USA.
J P RichieDepartment of Public Health Sciences, Penn State University College of Medicine, Hershey, PA, USA.
Pennsylvania State University · US

Funding

Penn State Clinical and Translational Science InstituteUL1TR002014 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI KRASCHNEWSKI, JENNIFER L. · 2016 to 2025
$33.7M
NCATS NIH HHS UL1 TR002014
6 · The paper itself

Abstract

BACKGROUND/

objectivesGlutathione (GSH) is the most abundant endogenous antioxidant and a critical regulator of oxidative stress. Maintenance of optimal tissues for GSH levels may be an important strategy for the prevention of oxidative stress-related diseases. We investigated if oral administration of liposomal GSH is effective at enhancing GSH levels in vivo. SUBJECTS/

methodsA 1-month pilot clinical study of oral liposomal GSH administration at two doses (500 and 1000 mg of GSH per day) was conducted in healthy adults. GSH levels in whole blood, erythrocytes, plasma and peripheral blood mononuclear cells (PBMCs) were assessed in 12 subjects at the baseline and after 1, 2 and 4 weeks of GSH administration.

resultsGSH levels were elevated after 1 week with maximum increases of 40% in whole blood, 25% in erythrocytes, 28% in plasma and 100% in PBMCs occurring after 2 weeks (P<0.05). GSH increases were accompanied by reductions in oxidative stress biomarkers, including decreases of 35% in plasma 8-isoprostane and 20% in oxidized:reduced GSH ratios (P<0.05). Enhancements in immune function markers were observed with liposomal GSH administration including Natural killer (NK) cell cytotoxicity, which was elevated by up to 400% by 2 weeks (P<0.05), and lymphocyte proliferation, which was elevated by up to 60% after 2 weeks (P<0.05). Overall, there were no differences observed between dose groups, but statistical power was limited due to the small sample size in this study.

conclusionsCollectively, these preliminary findings support the effectiveness of daily liposomal GSH administration at elevating stores of GSH and impacting the immune function and levels of oxidative stress.

Indexed as

AgedBiomarkersCytotoxicity, ImmunologicDietary SupplementsErythrocytesFemaleGlutathioneGlutathione DisulfideHumansImmunityKiller Cells, NaturalLeukocytes, MononuclearLiposomesLymphocyte ActivationMaleMiddle AgedBiomarkersGlutathioneGlutathione DisulfideLiposomes

Identifiers

PMID28853742
PMCPMC6389332
OpenAlexW2753421600

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.